.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
UBS
McKesson
Cipla
Federal Trade Commission
Deloitte
Express Scripts
Harvard Business School
Covington
Dow

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,187,341

« Back to Dashboard

Summary for Patent: 6,187,341

Title: Trovafloxacin mesylate tablet
Abstract:Compositions, especially in the form of tablets containing the polymorph II form of trovafloxacin mesylate, a lubricant, and microcrystalline cellulose (MC) as the diluent. Such compositions employing MC as a diluent exhibit good storage stability properties and dissolution.
Inventor(s): Johnson; Alton D. (New York, NY), Sinko; Christopher M. (Niantic, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/233,823
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

No matches for this query

International Patent Family for Patent: 6,187,341

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO)1094► Subscribe
Argentina012780► Subscribe
Australia1217399► Subscribe
Australia758381► Subscribe
Bulgaria103106► Subscribe
Brazil9900116► Subscribe
Canada2259698► Subscribe
China1227743► Subscribe
Colombia4810225► Subscribe
Algeria2712► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Fish and Richardson
Mallinckrodt
Accenture
Chubb
Johnson and Johnson
Moodys
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot